Follow
Sharif Tabebordbar
Sharif Tabebordbar
Co-Founder and CSO at Kate Therapeutics
Verified email at katetherapeutics.com
Title
Cited by
Cited by
Year
In vivo gene editing in dystrophic mouse muscle and muscle stem cells
M Tabebordbar, K Zhu, J Cheng, WL Chew, J Widrick, W Yan, C Maesner, E Wu, R ...
Science 351 (6271), 407-411, 2016
11862016
Braveheart, a Long Noncoding RNA Required for Cardiovascular Lineage Commitment
CA Klattenhoff, JC Scheuermann, LE Surface, RK Bradley, PA Fields, ...
Cell 152 (3), 570-583, 2013
10192013
Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction
L Zangi, KO Lui, A von Gise, Q Ma, W Ebina, LM Ptaszek, D Später, H Xu, ...
Nature biotechnology 31 (10), 898-907, 2013
7462013
A multifunctional AAV-CRISPR-Cas9 and its host response
WL Chew, M Tabebordbar, JKW Cheng, P Mali, EY Wu, AHM Ng, K Zhu, ...
Nature methods 13 (10), 868-874, 2016
6402016
Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species
M Tabebordbar, K Lagerborg, A Stanton, E King, S Ye, L Tellez, ...
Cell 184, 1-20, 2021
2212021
A Zebrafish Embryo Culture System Defines Factors that Promote Vertebrate Myogenesis across Species
C Xu, M Tabebordbar, S Iovino, C Ciarlo, J Liu, A Castiglioni, E Price, ...
Cell 155 (4), 909-921, 2013
1792013
Feeder-and serum-free establishment and expansion of human induced pluripotent stem cells
M Totonchi, A Taei, A Seifinejad, M Tabebordbar, H Rassouli, A Farrokhi, ...
International Journal of Developmental Biology 54 (5), 877, 2010
1042010
Skeletal Muscle Degenerative Diseases and Strategies for Therapeutic Muscle Repair
M Tabebordbar, ET Wang, AJ Wagers
Annual Review of Pathology: Mechanisms of Disease 8, 441-475, 2013
872013
Progress and promise towards safe induced pluripotent stem cells for therapy
A Seifinejad, M Tabebordbar, H Baharvand, LA Boyer, GH Salekdeh
Stem Cell Reviews and Reports 6 (2), 297-306, 2010
662010
Comparative proteome and transcriptome analyses of embryonic stem cells during embryoid body‐based differentiation
A Fathi, M Pakzad, A Taei, TC Brink, L Pirhaji, G Ruiz, ...
Proteomics 9 (21), 4859-4870, 2009
622009
In Situ Modification of Tissue Stem and Progenitor Cell Genomes
JM Goldstein, M Tabebordbar, K Zhu, LD Wang, KA Messemer, B Peacker, ...
Cell reports 27 (4), 1254-1264. e7, 2019
492019
Systemic administration of novel engineered AAV capsids facilitates enhanced transgene expression in the macaque CNS
AC Stanton, KA Lagerborg, L Tellez, A Krunnfusz, EM King, S Ye, ...
Med, 2022
262022
Effects of selenite and tellurite on growth, physiology, and proteome of a moderately halophilic bacterium
M Kabiri, MA Amoozegar, M Tabebordbar, K Gilany, GH Salekdeh
Journal of proteome research 8 (6), 3098-3108, 2009
262009
Pro-myogenic small molecules revealed by a chemical screen on primary muscle stem cells
SM Buchanan, FD Price, A Castiglioni, AW Gee, J Schneider, MN Matyas, ...
Skeletal muscle 10 (1), 1-14, 2020
92020
RNA-Guided Systems for In Vivo Gene Editing
AJ Wagers, M Tabebordbar, WL Chew, GM Church
US Patent App. 15/531,751, 2017
52017
Genome editing in neurosciences
R Jaenisch, F Zhang, F Gage
Springer Nature, 2017
42017
The system can't perform the operation now. Try again later.
Articles 1–16